2026 NPPES data Optometrist NPI 1861435638 O.D.
Verify on CMS →

THOMAS LOPRESTI, O.D.

Optometrist in PARAMUS, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
501
Medicare Part D claims · 276 beneficiaries · Optometrist avg: 257
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
90.7967/100
▲ 8 pts above national avg 83.1 · [object Object]

What the federal data shows

THOMAS LOPRESTI, O.D. reported a CMS MIPS final score of 90.7967/100 — above the 83.1 national average — and filed 501 Medicare Part D claims in 2023.

90.7967/100
MIPS score · +8 vs avg
501
Part D claims, 2023
73%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

THOMAS LOPRESTI, O.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 40% higher than 60% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about THOMAS LOPRESTI, O.D.?

High performer (top quartile)

NPI registry status

Active

Issued 06/13/2006

NPI 1861435638

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

501 95% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

90.7967/100 7.696700000000007% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Optometrist compares to other specialties among New Jersey providers

New Jersey providers

Optometrist share within New Jersey

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within New Jersey

Medicare quality performance — MIPS

THOMAS LOPRESTI, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

High performer (top quartile)
MIPS Final Score
90.7967/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 90.7967/100 vs national avg 83.1

0%100%National avg83%90.8%
MIPS final score (Optometrist) — 90.7967/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

THOMAS LOPRESTI, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 523 FOREST AVENUE, PARAMUS, NJ, 07652, with a listed phone of (201) 262-5070. NPI 1861435638 was issued on 06/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOPRESTI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 501 prescription claims written by this provider, covering 276 Medicare beneficiaries and totaling roughly $86K in drug spend, split 27% brand-name and 73% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 90.7967/100 for the 2023 performance year (Quality 99.5148, Cost 69.8076), compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

523 FOREST AVENUE
PARAMUS, NJ 07652

Provider Details

NPI 1861435638
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 06/13/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

90.7967
Final Score
Avg: 83.1
99.5148
Quality
69.8076
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where THOMAS LOPRESTI, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE CENTERS OF AMERICA LLC
BLOOMFIELD, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Above average

THOMAS LOPRESTI, O.D. — brand share 27.0%
Specialty average (est.)

27% brand-name claims vs 73% generic, on 501 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

501
Total Claims
$86K
Total Drug Cost
276
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
718
Total Day Supply
18,139
Brand vs Generic
27% brand / 73% generic
Brand Drug Cost
$71K
Generic Drug Cost
$16K
Antibiotic Claims
72

Patient Demographics

Average Patient Age
76.2 years
Avg HCC Risk Score
1.10
Gender Split
69% female / 31% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What THOMAS LOPRESTI, O.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Azelastine Hcl
68
Latanoprost
60
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
49
Doxycycline Monohydrate
38
Ketorolac Tromethamine
34
Restasis
Cyclosporine
25
Lumigan
Bimatoprost
23
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
20
Prednisolone Acetate
20
Cephalexin
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How THOMAS LOPRESTI, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

THOMAS LOPRESTI, O.D.'s 501 claims are above the specialty average of 257.

Nearby Optometrist Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as LOPRESTI.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is THOMAS LOPRESTI, O.D.'s specialty?
THOMAS LOPRESTI, O.D. specializes in Optometrist and practices in PARAMUS, New Jersey. Credentials: O.D..
How much does THOMAS LOPRESTI, O.D. prescribe under Medicare Part D?
In 2023, THOMAS LOPRESTI, O.D. wrote 501 Medicare Part D claims totaling $86K in drug costs for 276 beneficiaries.
What is THOMAS LOPRESTI, O.D.'s Medicare quality score?
THOMAS LOPRESTI, O.D. has a CMS MIPS Final Score of 90.7967/100 (Quality: 99.5148, Cost: 69.8076). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is THOMAS LOPRESTI, O.D. located?
THOMAS LOPRESTI, O.D. is located at 523 FOREST AVENUE, PARAMUS, NJ, 07652. Phone: (201) 262-5070.
What is THOMAS LOPRESTI, O.D.'s NPI number?
THOMAS LOPRESTI, O.D.'s National Provider Identifier (NPI) is 1861435638, issued on 06/13/2006.
Does THOMAS LOPRESTI, O.D. prescribe more brand-name or generic drugs?
THOMAS LOPRESTI, O.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $71K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does THOMAS LOPRESTI, O.D. prescribe most often?
Based on 2023 Medicare Part D data, THOMAS LOPRESTI, O.D.'s most frequently prescribed drugs include Azelastine Hcl, Latanoprost, Tobramycin-Dexamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does THOMAS LOPRESTI, O.D. accept Medicare?
THOMAS LOPRESTI, O.D. appears in CMS Medicare data with 501 Part D claims and 276 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify THOMAS LOPRESTI, O.D.'s credentials?
THOMAS LOPRESTI, O.D.'s NPI is 1861435638 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology